References

Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia

10.1161/hypertensionaha.123.19943 · 1979 · External reference

Prevalence and risk factors of cognitive impairment in Chinese patients with hypertension: a systematic review and meta-analysis

10.3389/fneur.2023.1271437 · 2023 · External reference

Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial

10.1001/jama.2018.21442 · 2019 · External reference

Risk factors and traditional Chinese medicine syndromes of mild cognitive impairment in community-dwelling hypertensive older adults

10.3389/fpubh.2025.1579557 · 2025 · External reference

Automatic detection of cerebral microbleeds using susceptibility weighted imaging and artificial intelligence

10.21037/qims-23-1319 · 2024 · External reference

Differences in lobar microbleed topography in cerebral amyloid angiopathy and hypertensive arteriopathy

10.1038/s41598-024-54243-1 · 2024 · External reference

Association of Cerebral Microbleeds with Cognitive Decline and Dementia

10.1001/jamaneurol.2016.1017 · 2016 · External reference

Imaging markers of cerebral small vessel disease are associated with Alzheimer's disease: a systematic review and meta-analysis

10.3389/fnagi.2025.1498636 · 2025 · External reference

Cerebral microbleeds are associated with mild cognitive impairment in patients with hypertension

10.1161/jaha.117.008453 · 2018 · External reference

Association of serum neurofilament light chain with cognitive impairment: findings from the National Health and nutrition examination survey

10.3389/fnagi.2025.1517663 · 2025 · External reference

Serum neurofilament light chain and cognition decline in US elderly: a cross-sectional study

10.1002/acn3.51929 · 2024 · External reference

Neurofilament light chain as a biomarker of global cognition in individuals with possible vascular mild cognitive impairment

10.1177/08919887241254469 · 2025 · External reference

Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik study

10.1007/s11357-023-00888-1 · 2024 · External reference

Association of Serum Neurofilament Light and Glial Fibrillary Acidic Protein with cerebral small vessel disease in nondemented middle-to-old aged population

10.1007/s12975-025-01359-9 · 2025 · External reference

2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension

10.11909/j.issn.1671-5411.2019.03.014 · 2018 · External reference

Cerebral microbleeds: a guide to detection and interpretation

10.1016/s1474-4422(09)70013-4 · 2009 · External reference

The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds

10.1212/wnl.0b013e3181c34a7d · 2009 · External reference

Cerebral microbleeds are associated with worse cognitive function: the Rotterdam scan study

10.1212/wnl.0b013e3182452928 · 2012 · External reference

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

10.2214/ajr.149.2.351 · 1987 · External reference

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

10.1016/s1474-4422(13)70124-8 · 2013 · External reference

The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment

10.1111/j.1532-5415.2005.53221.x · 2005 · External reference

Montreal cognitive assessment memory index score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease

10.1111/jgs.12742 · 2014 · External reference

Validity of the Montreal cognitive assessment (MoCA) index scores: a comparison with the cognitive domain scores of the Seoul neuropsychological screening battery (SNSB)

10.12779/dnd.2021.20.3.28 · 2021 · External reference

Examining the validity and utility of Montreal cognitive assessment domain scores for early neurocognitive disorders

10.1016/j.jamda.2022.12.028 · 2023 · External reference

Mild cognitive impairment--beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment

10.1111/j.1365-2796.2004.01380.x · 2004 · External reference

The performance of patients with cerebral microbleeds in different cognitive tests: a cross-sectional study

10.3389/fnagi.2023.1114426 · 2023 · External reference

Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease

10.1177/17474930211012837 · 2022 · External reference

Structural brain network disruption at preclinical stage of cognitive impairment due to cerebral small vessel disease

10.1016/j.neuroscience.2020.08.037 · 2020 · External reference

Cerebral microbleeds are associated with increased brain Iron and cognitive impairment in patients with cerebral small vessel disease: a quantitative susceptibility mapping study

10.1002/jmri.28092 · 2022 · External reference

Space and location of cerebral microbleeds, cognitive decline, and dementia in the community

10.1212/wnl.0000000000003983 · 2017 · External reference

Plasma Neurofilament light chain as a predictive biomarker for post-stroke cognitive impairment: a prospective cohort study

10.3389/fnagi.2021.631738 · 2021 · External reference

Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment

10.1038/s41598-024-59530-5 · 2024 · External reference

Association of Plasma Neurofilament Light with Small Vessel Disease Burden in nondemented elderly: a longitudinal study

10.1161/strokeaha.120.030302 · 2021 · External reference

Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease

10.1002/dad2.12396 · 2023 · External reference

Neurofilament light chain predicts future dementia risk in cerebral small vessel disease

10.1136/jnnp-2020-325681 · 2021 · External reference

Increased Neurofilament light chain is associated with increased risk of long-term mortality in cerebral small vessel disease

10.5853/jos.2021.04385 · 2022 · External reference

Cerebral small vessel disease mediates the association between homocysteine and cognitive function

10.3389/fnagi.2022.868777 · 2022 · External reference

A comparison of two analytical approaches for the quantification of Neurofilament light chain, a biomarker of axonal damage in multiple sclerosis

10.3390/ijms241310787 · 2023 · External reference